However, we posit where CHIP mutations are present in ctDNA at a VAF that approximates non-CHIP and lymphoma-specific mutations (e.g., RHOAG17V) it is likely that they are represented within the lymphoma cells; this assertion is supported by high concordance with genomic studies performed on the subset of patients on tumour tissue. Here, STUB1 is linked to neoplasm.